Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.
Two patients with a severe von Willebrand's disease characterized by no detectable factor VIII related antigen in their plasma received transfusions of cryoprecipitate. The bleeding time was corrected for a short period of time and returned to its pretransfusional value although the other parameters of the disease were still corrected. Electrophoretic and immunologic properties of factor VIII related antigen infused were determined serially after transfusion. Modifications of these properties occurred progressively after transfusion. The half disappearance time of F. VIII R.A. was determined and found to be considerably shorter than in hemophilic recipients. This study suggests an alteration in vivo of F. VIII R.A. infused into von Willebrand recipients.
D000328:Adult; D000941:Antigens / Q000032:analysis; D001803:Blood Transfusion; D002648:Child; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use; D005260:Female; D006207:Half-Life; D006801:Humans; D007123:Immunoelectrophoresis, Two-Dimensional; D008297:Male; D014842:von Willebrand Diseases / Q000276:immunology* / Q000628:therapy; D014841:von Willebrand Factor / Q000032:analysis
D000941:Antigens; D014841:von Willebrand Factor; D005169:Factor VIII